Yi-Feng Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi-Feng Guo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Fang Guo
Laboratory of Tumor Targeted Therapy, Shanghai Advanced Research Institute, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
2 shared publications Jun-Wei Gao
Department of Clinical Pharmacy, Shanghai First People's Hospital, Shanghai Jiao Tong University , Shanghai , China
1 shared publicationJunwei Gao
Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publicationMinghua Shang
Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publicationSheng-Cong Guo
College of Electric Computer, Sichuan University, Chengdu, China, ; Key Laboratory of Systems Biology, Chinese Academy of Sciences, Shanghai, China, and
1 shared publicationShuai Gao
Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 12 April 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (17) , 23088-23095
Effect ofCTLA-4gene polymorphisms on long-term kidney allograft function in Han Chinese recipients
Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients
- 12 April 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (17) , 23088-23095
Open AccessEffect ofCTLA-4gene polymorphisms on long-term kidney allograft function in Han Chinese recipients
Effect of CTLA-4 gene polymorphisms on long-term kidney allograft function in Han Chinese recipients
- Open Access
- 9 October 2014
- Published by Taylor & Francis in Renal Failure
- Vol. 37 (1) , 165-174
A deeper understanding of the association betweenCTLA4+49A/G and acute rejection in renal transplantation: an updated meta-analysis
To reevaluate the association between the costimulatory molecule cytotoxic T lymphocyte-associated antigen4 (CTLA4) single nucleotide polymorphism (SNP) +49A/G and acute rejection (AR) in renal transplantation, nine studies published before June 2013 were analyzed. Meta-analysis and cumulative meta-analysis (metacum) were performed for each genotype in a random/fixed effect model. The combined odds ratios (OR) with 95% confidence intervals (CI) were calculated to estimate the strength of the association. In the sensitivity analysis, a single study involved in the meta-analysis was deleted each time to investigate the influence of the individual data sets on the pooled ORs. Meta-analysis regression was used for some influence factors, such as year of publication, total number in each group (AR group and control group), ethnicity, the ratio of GG to GA + AA, the ratio of G to A in CTLA4 +49A/G. Overall, a significant correlation was noted between the CTLA4 SNP (+49A/G) and the risk of AR (for GG vs. AG + AA: OR = 1.35, 95% CI = 1.05–1.73, p = 0.02; for G vs. A: OR = 1.21, 95% CI = 1.03–1.42, p = 0.02), especially in the Asian subgroup (for GG vs. AG + AA: OR = 1.79, 95% CI = 1.15–2.78, p = 0.009; for G vs. A: OR = 1.47, 95% CI = 1.04–2.07, p = 0.03). Of the influence factors, the ratio of GG to GA+AA (p = 0.046) and the ratio of G to A (p = 0.017) were significant factors. In conclusion, our results suggest that CTLA4 +49A/G contribute to the risk of AR following renal transplantation.
- 9 October 2014
- Published by Taylor & Francis in Renal Failure
- Vol. 37 (1) , 165-174
Open AccessA deeper understanding of the association betweenCTLA4+49A/G and acute rejection in renal transplantation: an updated meta-analysis
To reevaluate the association between the costimulatory molecule cytotoxic T lymphocyte-associated antigen4 (CTLA4) single nucleotide polymorphism (SNP) +49A/G and acute rejection (AR) in renal transplantation, nine studies published before June 2013 were analyzed. Meta-analysis and cumulative meta-analysis (metacum) were performed for each genotype in a random/fixed effect model. The combined odds ratios (OR) with 95% confidence intervals (CI) were calculated to estimate the strength of the association. In the sensitivity analysis, a single study involved in the meta-analysis was deleted each time to investigate the influence of the individual data sets on the pooled ORs. Meta-analysis regression was used for some influence factors, such as year of publication, total number in each group (AR group and control group), ethnicity, the ratio of GG to GA + AA, the ratio of G to A in CTLA4 +49A/G. Overall, a significant correlation was noted between the CTLA4 SNP (+49A/G) and the risk of AR (for GG vs. AG + AA: OR = 1.35, 95% CI = 1.05–1.73, p = 0.02; for G vs. A: OR = 1.21, 95% CI = 1.03–1.42, p = 0.02), especially in the Asian subgroup (for GG vs. AG + AA: OR = 1.79, 95% CI = 1.15–2.78, p = 0.009; for G vs. A: OR = 1.47, 95% CI = 1.04–2.07, p = 0.03). Of the influence factors, the ratio of GG to GA+AA (p = 0.046) and the ratio of G to A (p = 0.017) were significant factors. In conclusion, our results suggest that CTLA4 +49A/G contribute to the risk of AR following renal transplantation.